[8-K] iREIT MarketVector Quality REIT Index ETF Reports Material Event

Rhea-AI Filing Summary

Darling Ingredients Inc. (DAR) filed a Form 144 indicating that Randall Stuewe intends to sell up to 35,000 shares of the company’s common stock through J.P. Morgan Securities on or after 08/04/2025 on the NYSE. The proposed transaction is valued at approximately $1.10 million, based on the aggregate market value disclosed. With 158,158,847 shares outstanding, the planned sale represents roughly 0.02 % of total shares.

The shares were acquired via an employee stock award on 03/02/2023. The filer reports a previous sale of 40,000 shares on 05/19/2025 that generated $1.36 million in gross proceeds. No adverse, non-public information is asserted, and the filing may serve as a Rule 10b5-1 notice.

• Issuer: Darling Ingredients Inc.
• Insider: Randall Stuewe (relationship not explicitly stated in filing excerpt)
• Broker: J.P. Morgan Securities LLC
• Class: Common Stock
• Planned sale volume: 35,000 shares
• Outstanding shares: 158.16 million

Positive

• None.

Negative

• Insider selling: Randall Stuewe plans to sell 35,000 shares after selling 40,000 shares three months prior, which could be perceived as a bearish signal.

Insights

Securities Analyst

TL;DR: Small insider sale; signal modestly negative but immaterial to float.

The Form 144 discloses a planned disposition equal to 0.02 % of shares outstanding, following a 40 k share sale three months earlier. While insider selling—especially by a key executive—can raise sentiment concerns, the absolute size is negligible and proceeds suggest routine diversification rather than a strategic shift. No operational data or guidance accompanies the notice, so fundamental outlook remains unchanged.

Corporate Governance Expert

TL;DR: Filing fulfills Rule 144 transparency; transaction appears compliant.

The filer affirms no undisclosed material information and references potential Rule 10b5-1 coverage, indicating adherence to insider-trading safeguards. Timely disclosure reduces regulatory risk. Investors should monitor cumulative selling patterns but, given the minimal percentage, governance impact is limited.

0000798359false00007983592025-08-042025-08-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 4, 2025

CENTERSPACE

(Exact name of Registrant as specified in its charter)

North Dakota

001-35624

45-0311232

(State or Other Jurisdiction of Incorporation or Organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

3100 10th Street SW, Post Office Box 1988, Minot, ND 58702-1988

(Address of principal executive offices) (Zip code)

(701) 837-4738

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed from last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐    Written communications pursuant to Rule 425 under the Securities Act

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Shares of Beneficial Interest, no par value			CSR			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

Centerspace (the "Company") issued an earnings release on August 4, 2025, announcing certain financial and operational results for the three and six months ended June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 and incorporated herein by reference.

The information in this Item 2.02 and the earnings release furnished as Exhibit 99.1 under Item 9.01, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 8.01 Other Events.

Effective July 31, 2025, the Company’s Board of Trustees (the “Board”) authorized a share repurchase program (the “Share Repurchase Program”) under which the Company may repurchase up to $100 million of its common shares of beneficial interest, no par value per share (the “Common Shares”), through July 31, 2026. Under the Share Repurchase Program, the Company may repurchase Common Shares from time to time in open market transactions, through privately negotiated transactions, through one or more accelerated repurchases, or otherwise, in accordance with the terms set forth in Rule 10b5-1 and Rule 10b-18 of the Exchange Act and other applicable legal requirements. The extent to which the Company repurchases Common Shares and the timing of such repurchases will depend on market conditions and other considerations as may be considered in the Company’s sole discretion. The Share Repurchase Program does not obligate the Company to repurchase any specific number of Common Shares, and there is no guarantee as to the exact number of Common Shares that will be repurchased by the Company, if any. The Company may initiate, suspend or discontinue purchases under the Share Repurchase Program at any time. Furthermore, the Share Repurchase Program may be modified, suspended or terminated at any time by the Board without prior notice.

ITEM 9.01    Financial Statements and Exhibits

(d)Exhibits

Exhibit
Number			Description
99.1			Earnings Release and Supplemental Operating and Financial Data, dated August 4, 2025.
104			Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL Document.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Centerspace
			By			/s/ Anne Olson
						Anne Olson
Date: August 4, 2025						President and Chief Executive Officer

FAQ

How many Darling Ingredients (DAR) shares are being sold under this Form 144?

Up to 35,000 common shares are proposed for sale.

What is the estimated value of the planned DAR share sale?

The aggregate market value disclosed is approximately $1.10 million.

What percentage of Darling Ingredients’ outstanding shares does 35,000 represent?

Roughly 0.02 % of the 158,158,847 shares currently outstanding.

Who is the insider selling Darling Ingredients shares?

The filing lists Randall Stuewe as the seller.

When is the proposed sale date for the DAR shares?

On or after 08/04/2025.

Which broker will execute the sale of DAR shares?

The broker of record is J.P. Morgan Securities LLC.